Bengaluru, Nov. 12 -- A small-cap pharmaceutical stock saw buying interest in today's trade after securing a fresh international vaccine supply award, strengthening its export pipeline and order visibility.

Panacea Biotec Ltd, with a market capitalisation of Rs. 2,449.42 crore, opened at Rs. 407.05 on the BSE against its previous close of Rs. 396.40. The stock touched an intraday high of Rs. 407.05, marking an increase of 2.69 percent from the previous close.

What's the News?

Panacea Biotec Ltd announced that it has received an award notification from the Pan American Health Organization (PAHO), the Regional Office of the World Health Organization, under a long-term agreement for the supply of Diphtheria-Tetanus-Pertussis-Hepatitis B-H...